Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir nanofiber patch for recurrent herpes labialis
IRCT20141124020073N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aciclovir in herpes labialis, sponsored by Isfahan University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on IRCT20141124020073N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141124020073N2.